British Medical Bulletin 42:70-74 (1986)
© 1986 The British Council
research-article |
NON-CHOLINERGIC NEUROTRANSMITTER ABNORMALITIES IN ALZHEIMER'S DISEASE
Institute of Neurology London
Merck Sharp & Dohme Research Laboratories Harlow Essex
Abstract
Apart from the damago to ascending cholinergic projections in Alzheimer's disease, biochemical studies on human brain post mortem have revealed a number of other neurochemical abnormalities. These include reductions in 5-hydroxytryptamine (5-HT) and 5-HT receptors, and in noradrenaline. There is also evidence of selective damage to somatostatin-containing elements in cerebral cortex, especially in the temporal lobe. Such other cortical peptides as enkephalins, neurotensin, cholecystokinin, thyrotropin-releasing hormone, substance P and vasoactive intestinal polypeptide are unaffected. Some regions of cerebral cortex show reduced concentrations of GABA.
The reduction in cortical somatostatin appears to be the most marked of these changes, and is the most clearly related to seventy of illness. All of the neurochemical deficits were most pronounced in younger patients.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. S. Zubenko, W. N. Zubenko, S. McPherson, E. Spoor, D. B. Marin, M. R. Farlow, G. E. Smith, Y. E. Geda, J. L. Cummings, R. C. Petersen, et al. A Collaborative Study of the Emergence and Clinical Features of the Major Depressive Syndrome of Alzheimer's Disease Am J Psychiatry, May 1, 2003; 160(5): 857 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T Francis, A. M Palmer, M. Snape, and G. K Wilcock The cholinergic hypothesis of Alzheimer's disease: a review of progress J. Neurol. Neurosurg. Psychiatry, February 1, 1999; 66(2): 137 - 147. [Abstract] [Full Text] |
||||
![]() |
K. M. Kolasa, C. Schmidt, and J. A. Bartlett Feeding Alzheimer's patients American Journal of Alzheimer's Disease and Other Dementias, May 1, 1989; 4(3): 17 - 20. [PDF] |
||||


